Publications

Henfling, Joseph A.; Chavira, David C.; Greving, Jeffrey J.; Lindblom, Scott C.; Maldonado, Frank J.; Vaughn, Mark R.

Abstract not provided.

Miller, A.K.; Vaughn, Mark R.

Numotech Inc. has developed the Numobag{trademark}, a disposable, lightweight, wound healing device which produces Topical Hyperbaric Oxygen Therapy (THOT). The Numobag{trademark} is cost effective and has been clinically validated to heal large skin lesions rapidly and has proven to arrest wound advancement from several insidious forms of biological attack including dermal anthrax, small pox, necrotizing fasciitis etc. The Numobag{trademark} can treat mass casualties wounded by chemical/radiological burns or damaging biological exposures. The Numobag{trademark} can be a frontline tool as an isolation unit, reducing cross-contamination and infection of medical personnel. The heightened oxygen content kills organisms on the skin and in the wound, avoids expensive hospital trash disposal procedures, and helps the flesh heal. The Numobag{trademark} requires high purity oxygen. Numotech Inc. is teaming with Sandia National Laboratories and Spektr Conversion in Russia to develop a cost effective, portable, low power oxygen generator.

Klarer, Paul R.; Vaughn, Mark R.; Baty, Roy S.; Gilbride, Jennifer F.; Adams, Jerry L.

Abstract not provided.